GWS
BNTX icon

Greykasell Wealth Strategies’s BioNTech BNTX Stock Holding History

Greykasell Wealth Strategies’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-91
Closed -$9.69K – 408
2025
Q2 		$9.69K Buy
+91
New +$9.19K ﹤0.01% 248

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Greykasell Wealth Strategies's BNTX Position: Q3 2025 in Review

Greykasell Wealth Strategies sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 91 shares — an estimated $9.69K sold.

Greykasell Wealth Strategies first reported a position in BNTX in Q2 2025 and held it in 1 quarter. The position peaked at $9.69K in Q2 2025. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Greykasell Wealth Strategies reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Greykasell Wealth Strategies sold 91 BioNTech shares in Q3 2025, an estimated $9.69K.
  • Greykasell Wealth Strategies first reported a position in BioNTech in Q2 2025 and held it in 1 quarter.
  • Greykasell Wealth Strategies's BioNTech position peaked at $9.69K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Greykasell Wealth Strategies's 13F filing for Q3 2025, filed 4 Nov 2025.